Startech Labs, Inc.
LAAB
$0.0126
-$0.0024-16.00%
| Weiss Ratings | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D+ | |||
| Rating Factors | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.49 | |||
| Price History | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -16.00% | |||
| 30-Day Total Return | -56.70% | |||
| 60-Day Total Return | -68.50% | |||
| 90-Day Total Return | 93.85% | |||
| Year to Date Total Return | -41.67% | |||
| 1-Year Total Return | 51.81% | |||
| 2-Year Total Return | -61.82% | |||
| 3-Year Total Return | -85.43% | |||
| 5-Year Total Return | -98.20% | |||
| 52-Week High % Change | -81.25% | |||
| 52-Week Low % Change | 130.77% | |||
| Price | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.08 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Mar 19, 2024 | |||
| 52-Week High Price (Date) | Dec 12, 2024 | |||
| Valuation | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 909.71K | |||
| Enterprise Value | 1.16M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | 0.00% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -2.21 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -36.21 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 60.65M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 802 255 4212 | |||
| Address | 244 Madison Avenue New York, NY 10016-2817 | |||
| Website | -- | |||
| Country | United States | |||
| Year Founded | 2013 | |||
| Profitability | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -32.00K | |||
| Net Income (TTM) | -61.60K | |||
| Net Income Avl. to Common (TTM) | -61.60K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 12.50% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 0.00% | |||
| Balance Sheet | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | -- | |||
| Cash Per Share (Q) | -- | |||
| Total Current Assets (Q) | -- | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -410.60K | |||
| Current Ratio (Q) | -- | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 410.60K | |||
| Total Debt (Q) | 248.90K | |||
| Total Liabilities (Q) | 410.60K | |||
| Total Common Equity (Q) | -410.60K | |||
| Cash Flow | LAAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 31.20K | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -31.20K | |||
